Detail: SPC/CZ2025/944
MS Word DOCX
Adobe PDF
Data obtained on: 13.06.2025 21:32.
Latest update: IPO 13.06.2025
WARNING: This printout has a merely information character and the details have been drawn from the Web. In case you think, that the information given is not correct, please, contact the Industrial Property Office.
Latest update: IPO 13.06.2025
WARNING: This printout has a merely information character and the details have been drawn from the Web. In case you think, that the information given is not correct, please, contact the Industrial Property Office.
Basic bibliography
(21) Application number 2025-944 |
EP application number 11748067.3 |
(86) PCT application number US2011026079 |
(87) Number of published PCT application (WO) WO2011106528 |
(22) Filing date 07.05.2025 |
Priority (32) Priority date: 12.11.2010 (31) Priority application number: 413172 P (33) Priority country: United States of America (32) Priority date: 20.05.2010 (31) Priority application number: 346595 P (33) Priority country: United States of America (32) Priority date: 24.02.2010 (31) Priority application number: 307797 P (33) Priority country: United States of America |
Date of the first authorization in the CZ 14.11.2024 |
Date of the first authorization in the ECC 14.11.2024 |
Number of the first authorization in the CZ EU/1/24/1866 |
Number of the first authorization in the EEC EU/1/24/1866 |
Country of the first authorization in the EEC Evropská unie |
Product indication CS: ELAHERE - mirvetuximab soravtansin |
Product type léčivý přípravek |
(71/73) Applicant/Holder ImmunoGen, Inc., 1 North Waukegan Road, North Chicago, 60064, Illinois, United States of America |
(72/75) Inventor AB, Olga, Millis
Massachusetts 02054, United States of America TAVARES, Daniel, Natick
Massachusetts 01760, United States of America RUI, Lingyun, Weston
Massachusetts 02493, United States of America PAYNE, Gillian, Waban
Massachusetts 02468, United States of America GOLDMAKHER, Viktor S., Newton
Massachusetts 02459, United States of America ImmunoGen, Inc., North Chicago, 60064, Illinois, United States of America |
Representative JUDr. Michal Havlík, advokát, Hálkova 1406/2, 120 00 Praha 2, Nové Město, Czech Republic |
(40) Publication date 28.05.2025 |
Status Application filed Download xml with status |
Type SPC – forein application |
Time line
07.05.2025
application for a certificate filed
28.05.2025
application for a certificate published
Abstract
Picture
Documents
List of proceedings items
| Authorized person / Location: Ing. Kateřina Kadeřábková / Ing. Kateřina Kadeřábková | ||||||||
| Item number | Registration date | Date of dispatch | Item name | Date of attending the request | Effective date | Fee paid | Date of payment | Official Journal Number |
| 2 | PUBLIKACE ŽÁDOSTI O UDĚLENÍ DODATKOVÉHO OSVĚDČENÍ | 2025/22 published: 28.05.2025 | ||||||
| 1 | 07.05.2025 | žádost o udělení dodatkového osvědčení | Yes | 16.05.2025 | ||||
Authorized person / Location: Ing. Kateřina Kadeřábková / Ing. Kateřina Kadeřábková
Item number
2
Item name
PUBLIKACE ŽÁDOSTI O UDĚLENÍ DODATKOVÉHO OSVĚDČENÍ
Official Journal Number
2025/22 published: 28.05.2025
Item number
1
Registration date
07.05.2025
Item name
žádost o udělení dodatkového osvědčení
Fee paid
Yes
Date of payment
16.05.2025
Holder transfers and changes
License
Other rights and other decisive data
Errata
Publications in the IPO Official Bulletin
2025/22 published: 28.05.2025 - PUBLIKACE ŽÁDOSTI O UDĚLENÍ DODATKOVÉHO OSVĚDČENÍ |
Document family
Parent documents: CZ/EP 2538976 |